GILD · ISSUER CIK 882095
GILEAD SCIENCES, INC.
Between Aug 1, 2026 and Oct 29, 2026, 8 GILEAD SCIENCES, INC. insiders reported $0.00 of open-market purchases and $15.9M of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 11 of 11 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$15.9MInsider selling
−$15.9MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202616:17 | Oct 15, 2026 | GILD | Chief Financial Officer | S · Sell10b5-1 | $156.22 | −3,000 | 161,096 | -2% | −$469K | ||
| Oct 16, 202616:12 | Oct 15, 2026 | GILD | Chief Comm & Corp Aff Officer | S · Sell10b5-1 | $156.22 | −3,000 | 113,684 | -3% | −$469K | ||
| Oct 2, 202616:40 | Oct 1, 2026 | GILD | Chairman & CEO, Director | S · Sell10b5-1 | $147.90 | −15,000 | 566,683 | -3% | −$2.2M | ||
| Sep 23, 202616:17 | Sep 22, 2026 | GILD | SVP, Controllership | M · Exercise | — | +2,223 | 2,223 | New | — | ||
| Sep 23, 202616:17 | Sep 22, 2026 | GILD | SVP, Controllership | F · Tax | $152.67 | −768 | 1,455 | -35% | $117K | ||
| Sep 16, 202616:30 | Sep 15, 2026 | GILD | Chief Financial Officer | S · Sell10b5-1 | $145.29 | −3,000 | 164,096 | -2% | −$436K | ||
| Sep 16, 202616:27 | Sep 15, 2026 | GILD | Chief Comm & Corp Aff Officer | S · Sell10b5-1 | $144.22 | −3,000 | 116,684 | -3% | −$433K | ||
| Sep 11, 202618:30 | Sep 10, 2026 | GILD | Chief Financial Officer | M · Exercise | — | +2,797 | 168,443 | +2% | — | ||
| Sep 11, 202618:30 | Sep 10, 2026 | GILD | Chief Financial Officer | F · Tax | $144.81 | −1,347 | 167,096 | -1% | $195K | ||
| Sep 11, 202618:29 | Sep 10, 2026 | GILD | Chief Medical Officer | M · Exercise | — | +533 | 19,785 | +3% | — | ||
| Sep 11, 202618:29 | Sep 10, 2026 | GILD | Chief Medical Officer | F · Tax | $144.81 | −263 | 19,522 | -1% | $38K | ||
| Sep 11, 202618:28 | Sep 10, 2026 | GILD | Chief Comm & Corp Aff Officer | M · Exercise | — | +2,797 | 121,031 | +2% | — | ||
| Sep 11, 202618:28 | Sep 10, 2026 | GILD | Chief Comm & Corp Aff Officer | F · Tax | $144.81 | −1,347 | 119,684 | -1% | $195K | ||
| Sep 11, 202618:28 | Sep 10, 2026 | GILD | EVP Gen Counsel, Legal & Comp | M · Exercise | — | +590 | 9,044 | +7% | — | ||
| Sep 11, 202618:28 | Sep 10, 2026 | GILD | EVP Gen Counsel, Legal & Comp | F · Tax | $144.81 | −285 | 8,759 | -3% | $41K | ||
| Sep 11, 202618:27 | Sep 10, 2026 | GILD | Chairman & CEO, Director | M · Exercise | — | +8,780 | 585,913 | +2% | — | ||
| Sep 11, 202618:27 | Sep 10, 2026 | GILD | Chairman & CEO, Director | F · Tax | $144.81 | −4,230 | 581,683 | -1% | $613K | ||
| Sep 2, 202616:12 | Sep 1, 2026 | GILD | Chairman & CEO, Director | S · Sell10b5-1 | $148.64 | −15,000 | 577,133 | -3% | −$2.2M | ||
| Aug 27, 202618:44 | Aug 26, 2026 | GILD | Director | S · Sell10b5-1 | $148.62 | −18,000 | 12,894 | -58% | −$2.7M | ||
| Aug 27, 202618:44 | Aug 26, 2026 | GILD | Director | M · Exercise10b5-1 | $61.06 | +18,000 | 23,176 | +348% | $1.1M | ||
| Aug 21, 202619:22 | Aug 20, 2026 | GILD | Director | S · Sell10b5-1 | $145.02 | −5,000 | 10,066 | -33% | −$725K | ||
| Aug 21, 202619:22 | Aug 20, 2026 | GILD | Director | M · Exercise10b5-1 | $67.04 | +5,000 | 10,401 | +93% | $335K | ||
| Aug 18, 202619:06 | Aug 17, 2026 | GILD | Chief Financial Officer | S · Sell10b5-1 | $138.36 | −3,000 | 165,646 | -2% | −$415K | ||
| Aug 18, 202618:54 | Aug 17, 2026 | GILD | Chief Comm & Corp Aff Officer | S · Sell10b5-1 | $137.64 | −28,000 | 118,234 | -19% | −$3.9M | ||
| Aug 18, 202618:54 | Aug 17, 2026 | GILD | Chief Comm & Corp Aff Officer | M · Exercise10b5-1 | $67.07 | +25,000 | 146,234 | +21% | $1.7M | ||
| Aug 11, 202616:51 | Aug 10, 2026 | GILD | EVP Gen Counsel, Legal & Comp | M · Exercise | — | +6,002 | 11,362 | +112% | — | ||
| Aug 11, 202616:51 | Aug 10, 2026 | GILD | EVP Gen Counsel, Legal & Comp | F · Tax | $133.06 | −2,908 | 8,454 | -26% | $387K | ||
| Aug 4, 202617:40 | Aug 3, 2026 | GILD | Chairman & CEO, Director | S · Sell10b5-1 | $130.31 | −15,000 | 592,133 | -2% | −$2.0M |